: 22325690  [PubMed - indexed for MEDLINE]671. J Heart Lung Transplant. 2012 Feb;31(2):117-26. doi:10.1016/j.healun.2011.12.001.The Fourth INTERMACS Annual Report: 4,000 implants and counting.Kirklin JK(1), Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB.Author information: (1)Division of Cardiovascular, University of Alabama at Birmingham, Birmingham,Alabama 35294, USA. jkirklin@uab.eduThe Fourth Annual Report of the Interagency Registry for Mechanically AssistedCirculatory Support (INTERMACS) summarizes and analyzes the first 5 years ofpatient and data collection. With more than 4,000 patients entered into thedatabase, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adultprimary implant population is provided, and the recent composition of patientprofiles is examined. Current actuarial survival with continuous-flow pumpsexceeds 80% at 1 year and 70% at 2 years.Copyright Â© 2012. Published by Elsevier Inc.